📰 Merck Sharp News
Page 78 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
March 4, 2022
/PRNewswire/ -- Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo Park), a leading global microbiome anti-cancer drug development company,...
March 4, 2022
Adding olaparib to first-line abiraterone improved radiographic progression-free survival in metastatic castration-resistant prostate cancer.
March 3, 2022
The COVID-19 pandemic spurred a global response to create safe and effective vaccines at an unprecedented speed.
March 3, 2022
A look at how the competition authorities in Austria enforce provisions governing abuse of dominance, including sanctions, procedures and appeals.
March 3, 2022
A quick look at the key legal and regulatory provisions governing abuse of dominance in United Kingdom, including the types of conduct that constitute abuse and available defences.
March 2, 2022
Placebo and nocebo effects can greatly affect the interpretation of outcomes of trials on chronic peripheral neuropathic pain therapies, as demonstrated in a systematic review and meta-analysis.
March 1, 2022
China’s National Healthcare Security Administration published the 2021 National Reimbursement Drug List, implementing greater pricing discounts than those seen in 2020. Out of 117 drugs negotiated, 74 were successfully added to the 2021 NRDL, including 67 with exclusivity.
February 25, 2022
UPC Committee holds inaugural meeting; Mattel secures win against Thomas & Friends counterfeits; Irish Supreme Court seeks CJEU clarity; Andorra trademark rejected
February 25, 2022
/PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics,...
February 25, 2022
DAEJEON, South Korea, Feb. 25, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the developm...